Chimerix, Inc. (CMRX): Price and Financial Metrics


Chimerix, Inc. (CMRX)

Today's Latest Price: $1.67 USD

0.03 (1.83%)

Updated Feb 14 6:55pm

Add CMRX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 339 in Biotech

See all "A" rated Strong Buy stocks

CMRX Stock Summary

  • Of note is the ratio of Chimerix Inc's sales and general administrative expense to its total operating expenses; merely 7.55% of US stocks have a lower such ratio.
  • The ratio of debt to operating expenses for Chimerix Inc is higher than it is for about just 7.65% of US stocks.
  • Revenue growth over the past 12 months for Chimerix Inc comes in at 153%, a number that bests 96.01% of the US stocks we're tracking.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Chimerix Inc are IOTS, INSM, TELL, ABUS, and ADMP.
  • Visit CMRX's SEC page to see the company's official filings. To visit the company's web site, go to www.chimerix.com.
CMRX Daily Price Range
CMRX 52-Week Price Range

CMRX Stock Price Chart More Charts


CMRX Price/Volume Stats

Current price $1.67 52-week high $4.40
Prev. close $1.64 52-week low $1.25
Day low $1.62 Volume 208,900
Day high $1.68 Avg. volume 335,410
50-day MA $1.98 Dividend yield N/A
200-day MA $2.50 Market Cap 102.51M

Chimerix, Inc. (CMRX) Company Bio


Chimerix is a biopharmaceutical company dedicated to discovering, developing and commercializing novel, oral antivirals in areas of high unmet medical need. The company was founded in 2000 and is based in Durham, North Carolina.


CMRX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CMRX Latest Social Stream


Loading social stream, please wait...

View Full CMRX Social Stream

CMRX Price Returns

1-mo -18.14%
3-mo -17.33%
6-mo -28.94%
1-year -16.08%
3-year -71.93%
5-year -95.91%
YTD -17.73%
2019 -21.01%
2018 -44.49%
2017 0.65%
2016 -48.60%
2015 -77.77%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.6021 seconds.